| Methods |
RCT, multi‐centre study (6 centres) |
| Participants |
101 participants (101 IVF/ICSI cycles) analysed |
| Interventions |
COH included recombinant FSH (recFSH; Puregon) in flexible multi‐dose GnRH antagonist protocol (orgalutran). Triggering was randomly performed by 10,000 IU HCG (Pregnyl) or 0.1 mg GnRH agonist (triptorelin) |
| Outcomes |
Serum concentrations of LH, FSH, E2 and P4 were measured at 0, 12, 36 and 108 hours after triggering |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
Insufficient information: Full text was unavailable |
| Allocation concealment (selection bias) |
Unclear risk |
Insufficient information: Full text was unavailable |
| Blinding (performance bias and detection bias)
FOR OHSS OUTCOME |
Unclear risk |
Insufficient information: Full text was unavailable |
| Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Insufficient information: Full text was unavailable |
| Selective reporting (reporting bias) |
Unclear risk |
Insufficient information: Full text was unavailable |
| Other bias |
Unclear risk |
Insufficient information: Full text was unavailable |
